The FoxO1 inhibitor was also able to reduce the proliferation of CLL cells cocultured with HS5CD40L,IL-4,IL-21, and this was further decreased when combined with ibrutinib (Figure 7, C and D). This evidence concerns the gene IL21 and B-cell chronic lymphocytic leukemia.